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Abstract
 
The neurodegenerative changes in Alzheimer’s disease (AD) are elicited by the accumulation of
 
 
 
-amyloid peptides (A
 
 
 
), which damage neurons either directly by interacting with compo-
nents of the cell surface to trigger cell death signaling or indirectly by activating astrocytes and
microglia to produce inflammatory mediators. It has been recently proposed that the p75 neu-
rotrophin receptor (p75
 
NTR
 
) is responsible for neuronal damage by interacting with A
 
 
 
. By us-
ing neuroblastoma cell clones lacking the expression of all neurotrophin receptors or engi-
neered to express full-length or various truncated forms of p75
 
NTR
 
, we could show that p75
 
NTR
 
is involved in the direct signaling of cell death by A
 
 
 
 via the function of its death domain. This
signaling leads to the activation of caspases-8 and -3, the production of reactive oxygen inter-
mediates and the induction of an oxidative stress. We also found that the direct and indirect
(inflammatory) mechanisms of neuronal damage by A
 
 
 
 could act synergistically. In fact, TNF-
 
 
 
and IL-1
 
 
 
, cytokines produced by A
 
 
 
-activated microglia, could potentiate the neurotoxic ac-
tion of A
 
 
 
 mediated by p75
 
NTR
 
 signaling. Together, our results indicate that neurons express-
ing p75
 
NTR
 
, mostly if expressing also proinflammatory cytokine receptors, might be preferen-
tial targets of the cytotoxic action of A
 
 
 
 in AD.
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Introduction
 
Alzheimer’s disease (AD)
 
*
 
 is characterized by progressive
loss of neurons, formation of fibrillary tangles within
neurons, and numerous plaques in affected brain regions.
According to the “
 
 
 
-amyloid cascade hypothesis,” the
key pathogenetic event responsible for the degenerative
changes in neurons is the excessive formation and/or ac-
cumulation of fibrillar 
 
 
 
-amyloid peptides (A
 
 
 
), a set of
39–43 amino acid (aa) peptides derived from the cleavage
by 
 
 
 
- and 
 
 
 
-secretases of a membrane glycoprotein,
named 
 
 
 
-amyloid precursor protein (APP) (1–3). A
 
 
 
 are
neurotoxic in vitro
 
,
 
 and this cytotoxicity correlates with
their 
 
 
 
-sheet structure and fibrillar state (4–6). However
recent findings have shown that not only fibrils, but even
protofibrils and small soluble oligomers of A
 
 
 
 can be neu-
rotoxic (7).
Two main mechanisms have been postulated to be re-
sponsible for the neurotoxicity by A
 
 
 
: (i) A
 
 
 
 may interact
with components of cell membranes and thus injure neu-
rons directly (4–8) and/or enhance the vulnerability of
neurons by a variety of common insults, such as excitotox-
icity, hypoglycemia, or peroxidative damage (9); (ii) A
 
 
 
may damage neurons indirectly by activating microglia and
astrocytes to produce toxic and inflammatory mediators,
such as nitric oxide (NO), cytokines, and reactive oxygen
intermediates (ROI) (10–16).
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Neuronal Damage by A
 
 
 
 Is Mediated by p75
 
NTR
 
 Signaling
 
The mechanisms by which A
 
 
 
 interact with the cell sur-
face remain to be clarified. Besides interacting with phos-
pholipids of cellular plasmamembrane and forming selec-
tive cation channels and/or disrupting membrane integrity
by virtue of their lipophilic nature (17–19), A
 
 
 
 bind to a
variety of cell surface receptors, such as scavenger receptors
(13) and NH
 
2
 
-formylpeptide receptor 2 in microglia (20),
advanced glycation end products receptors (RAGE) in
neurons and microglia (21), serpin-enzyme complex recep-
tor (22), 
 
 
 
-7-nicotinic acetylcholine receptor
 
 
 
(
 
 
 
7NAChR)
(23), neurotrophin receptor p75 (p75
 
NTR
 
) (24–25), amy-
loid precursor protein (APP) (26) and a 
 
 
 
-amyloid binding
protein (BBP) containing a G protein-coupling module
(27) in neurons. Some of these binding interactions (21,
23–27) have been correlated with the direct neurotoxicity
of A
 
 
 
. The multiplicity of the receptors involved raises the
problem of the specificity of their interactions with A
 
 
 
 and
active roles in signaling cell death.
p75
 
NTR
 
 binds NGF and the other neurotrophins (28)
and belongs to the family of death receptors (29, 30). In re-
cent years, several groups have shown that p75
 
NTR
 
 medi-
ates both ligand-dependent and ligand-independent apop-
tosis (31–37) including that by A
 
 
 
 (24, 25). Furthermore,
the cholinergic neurons of the basal forebrain, which are
early and severely affected in AD, express high levels of
p75
 
NTR
 
, whereas the cholinergic neurons of the brainstem,
which do not express p75
 
NTR
 
, remain undamaged (38–
40). However, despite the data showing that p75
 
NTR
 
 binds
A
 
 
 
 (24, 25), it is not known whether this receptor directly
partakes to the cell death signaling or functions as a cellular
anchor for the interaction between A
 
 
 
 and the cell mem-
brane, an interaction that would allow for the toxic activity
of A
 
 
 
 independently of any p75
 
NTR
 
 activation.
p75
 
NTR
 
 is endowed with an independent signaling ca-
pacity (33, 41, 42). The cytoplasmic region of p75
 
NTR
 
 con-
tains a putative death domain (DD) and a juxtamembrane
intracellular domain (JICD). The DD exhibits similarities
and differences with respect to the DDs of TNFR and Fas
(43–45), and these structural differences would result in dif-
ferent mechanisms of recruitment and signaling by the
p75
 
NTR
 
 DD with regard to the self association of receptor
moieties and their interaction with other cytoplasmic fac-
tors (46–49). The JICD would be able to interact with cy-
toplasmic adaptor proteins and to signal cell death (46, 49–
52). Notwithstanding these findings, the exact functions of
the two regions of the intracellular domain of p75
 
NTR
 
 re-
main to be understood.
In this work we have addressed two problems. On the
basis of the previous findings by others that p75
 
NTR
 
 is in-
volved in the neurotoxicity by A
 
 
 
 (24, 25) we have in-
vestigated the mechanism of this involvement. To this
purpose, A
 
 
 
 were tested for the neuronal toxicity on a
SK-N-BE neuroblastoma cell line devoid of all neurotro-
phin receptors, and on several SK-N-BE derived cell
clones either expressing the full-length or truncated forms
of p75
 
NTR
 
. Our results were that p75
 
NTR
 
 plays a direct role
in cell death by A
 
 
 
 through the signaling function of the
DD, the activation of caspase-8 and oxidative stress. The
 
second problem concerns the possibility of a synergistic
cooperation between the direct and indirect (inflamma-
tory) mechanisms of neuronal damage by A
 
 
 
. The results
obtained indicate that this is the case because TNF-
 
 
 
 and
IL-1
 
 
 
, cytokines produced by A
 
 
 
-activated glial cells,
could potentiate the p75
 
NTR
 
-mediated direct neurotoxic
action of A
 
 
 
.
 
Materials and Methods
 
A
 
 
 
-Peptides.
 
A
 
 
 
(25–35), A
 
 
 
(1–40), A
 
 
 
(1–42), and A
 
 
 
(35–
25) were from Bachem AG. A
 
 
 
(25–35) was dissolved at 1.5 mM
in PBS, A
 
 
 
(1–40) at 1.5 mM in double-distilled water to be next
diluted at 250 
 
 
 
M in PBS, and A
 
 
 
(1–42) at 500 
 
 
 
M in double-
distilled water. Fibrillogenesis by A
 
 
 
(25–35) was rapid (minutes)
at room temperature, whereas A
 
 
 
(1–40) and A
 
 
 
(1–42) required
5–6 d at 37
 
 
 
C. A
 
 
 
(35–25) was dissolved as A
 
 
 
(25–35), but did
not form fibrils. Fibrillogenesis was monitored by thioflavine test
(16) before the experiments. When A
 
 
 
 were dissolved in DMSO
they did not form fibrils and remain in solution.
 
p75
 
NTR
 
 and Tropomyosin-related Kinase A Constructs.
 
The con-
struct encoding for the wild-type (wt) p75
 
NTR
 
 (pCEP4
 
 
 
-p75)
was generated by cloning the full-length human p75
 
NTR
 
 cDNA
into the PvuII site of the pCEP4
 
 
 
 mammalian expression vector
which carries the 
 
hygro
 
 resistance gene (see Fig 1 A; Invitrogen).
The p75
 
 
 
DD mutant, lacking aa from 352 to 427, was generated
according to Hantzopoulos (53). The other deletion mutants
p75
 
 
 
ECD, p75
 
 ICD, and p75 JICD were obtained by PCR
using specific primers and cloning the respective products into
the pCEP4  vector. Tropomyosin-related kinase (Trk)A expres-
sion plasmid was obtained by inserting the full-length cDNA en-
coding for the human TrkA receptor (54) into the episomal ex-
pression vector pCEP9  which carries the neo resistance gene.
Cell Clones. The human neuroblastoma SK-N-BE cell line,
which expresses neither p75NTR nor TrkA (BENTR-free) (34)
was grown in RPMI 1640 medium (BioWhittaker) containing
FBS (15% vol/vol; Life Technologies, Inc.), glutamine (2.0 mM),
and gentamycin (50  g/ml) and transfected by the liposome
technique (Lipofectin Reagent; GIBCO BRL) (55) with 10  g
of each of the p75 constructs or with the TrkA codifying plasmid.
As control BENTR-free cells were also transfected with the two
empty vectors. Transfected cells were selected in complete me-
dium containing either hygromycin (150  g/ml) or G418 (300
 g/ml) (Roche Molecular Biochemicals). The antibiotic-resis-
tant clones were characterized for expression of wt and mutated
p75NTR proteins or the wt TrkA protein. The SK-N-BE derived
cell clones generated were (see Fig. 1): (i) BEp75 expressing the
full-length p75NTR; (ii) BEp75 ECD lacking the four cysteine-
rich repeats of the extracellular domain (aa 36–230); (iii)
BEp75 ICD lacking the whole intracellular region (aa 280–427);
(iv) BEp75 DD, lacking the DD (aa 352–427); (v) BEp75 JICD
missing the intracellular JICD (aa 275–340); and (vi) BETrkA ex-
pressing the full-length TrkA protein. BETrkA was further trans-
fected with the plasmid encoding the full-length p75NTR and
derived cell clones (BEp75TrkA) were selected with both hygro-
mycin and G418.
Western Immunoblot and Immunocytochemistry Analysis. Immu-
noblotting was used to test the cellular levels of the various forms
of p75NTR and TrkA. Cells were lysed, fractioned by 8% SDS-
PAGE and transferred onto nitrocellulose filters as described pre-
viously (34). Nitrocellulose filters were probed with one of the
following antibodies: (i) anti-p75NTR 9992 polyclonal antiserum909 Perini et al.
raised against the intracellular region (provided by M.V. Chao,
New York University School of Medicine, New York, NY) (see
Fig. 1 B); (ii) anti-TrkA rabbit polyclonal antibody (Santa Cruz
Biotechnology, Inc.). The p75NTR and TrkA proteins were de-
tected with a HRP-conjugated secondary antibody (Amersham
Pharmacia Biotech) and revealed by the ECL method (Amersham
Pharmacia Biotech). The expression level of p75NTR in BEp75
cell clones was 3–5-fold higher than in PC12 cells (34). The lo-
calization in the plasmamembrane of the various p75NTR and
TrkA proteins was detected immunohistochemically using either
the mAb ME20.4 (a gift from M.V. Chao) raised against the
p75NTR extracellular domain or polyclonal antiserum 9992 (see
Fig. 1 C) or anti-TrkA rabbit polyclonal antibody as described
previously (34).
Experimental Protocol. Cell clones were plated at 12,500 cells/
cm2 for microscopic analysis and at 30,000 cells/cm2 for MTS as-
say. At the onset of the experimental treatments, the growth me-
dium was replaced with a fresh complete RPMI 1640 medium
containing 1% (vol/vol) FBS. Cultures were then exposed for
various times to (i) A  peptides (1–42 or 1–40 or 25–35) in fibril-
lary state, (ii) human recombinant nerve growth factor- 
(hrNGF- ) (Sigma-Aldrich), (iii) anti–human p75NTR mAb 8211
(Chemicon Int., Inc.) (56); or (iv) staurosporine (Calbiochem). In
some instances, these treatments were also preceded by 2-h expo-
sure to one of the following agents: Z-VAD-FMK (100  M;
Calbiochem), a nonspecific inhibitor of caspases; Z-IETD-FMK
(20  M; Calbiochem), a specific inhibitor of caspase-8; human
recombinant TNF-  (10 ng/ml hrTNF- ) or 20 ng/ml IL-1 
(PeproTech EC Ltd.); or 100 nM diphenyleneiodonium (DPI)
(Sigma-Aldrich). All the experiments throughout the work were
performed by using 20  M A (25–35) or 5  M A (1–40) and
A (1–42) since, on the basis of preliminary experiments, these
concentrations correspond to those giving the maximal cytotox-
icity in our experimental conditions. However, the cytotoxic ef-
fect of A  started to be detectable at a rather low concentration
of A  ( 100 nM).
Assessment of Cell Damage and Viability. Cell damage was an-
alyzed by means of epifluorescence microscopy after staining the
cells with a solution 1:1 (vol/vol) of acridine orange (AO; filter
setting for FITC) and ethidium bromide (EB; filter setting for
rhodamine) (both at 0.1 mg/ml in PBS; Molecular Probes), a
procedure that reveals both apoptosis and necrosis (57). Annexin
V-FITC binding test (Roche Molecular Biochemicals) evaluated
by epifluorescence microscopy was also used for the detection of
apoptosis in cells treated with NGF or mAb 8211, according to
the manufacturer’s procedure. This test was not suitable for cell
treated with A  since these peptides interact with the complex
Annexin V-FITC giving a diffuse fluorescence at the microscopic
analysis. Cell viability was also assessed by using an MTS (3-[4,5-
dimethylthiazol-2-yl]-5-[3-carboxymethoxyphenyl]-2-[4-sulfo-
phenyl]-2H-tetrazolium, inner salt) assay kit (Promega).
Assay of Caspase Activity. Cells were lysed in lysis buffer (10
mM Tris-HCl, pH 7.5, 10 mM NaH2PO4/Na2HPO4, 130 mM
NaCl, 1% Triton X-100, 10 mM NaPPi). Cell lysates (30–50  g
protein) were incubated for 90 min at 37 C with 20  M of
fluorogenic substrate: caspase-3, Ac-DEVD-AMC or caspase-8,
Z-IETD-AFC (both from BD PharMingen) according to the
manufacturer’s instructions.
Expression of TNF and IL-1 Receptors. BEp75 cell clones in
suspension were first treated for 1 h at 4 C with primary mAb
anti-TNFR55 H398 (donated by P. Scheurich, University of
Stuttgart, Stuttgart Germany), mAb anti-TNFR75 utr-1 (Bachem;
Peninsula Laboratories, Inc.) or mAb anti–IL-1RI (a gift from A.
Mantovani, Istituto Mario Negri, Milano, Italy). After cell wash-
ing, the secondary biotin-conjugated IgG (Sigma-Aldrich) was
added for 30 min at 4 C, followed by several washings and addi-
tion of 10  l of streptavidin-phycoerythrin (Sigma-Aldrich).
Cytofluorographic analysis was performed on a FACScan™ (Bec-
ton Dickinson) using CELLQuest™ software.
Statistical Analysis. Multiple data points were compared by
one-way ANOVA test with posthoc Dunnett multiple compari-
son test. The interaction between A  and TNF-  or IL-1  was
determined by two-way ANOVA. All statistical tests were per-
formed by SPSS 10 statistical package (SPSS, Inc.).
Results
Expression of p75NTR and the Cytotoxicity of A . We first
investigated the effect of these peptides on the BENTR-
free cells (34), and on BEp75 (Fig. 1). Our results showed
that A (25–35), A (1–40), and A (1–42) were able to in-
duce cell death in BEp75 cells, while being totally harmless
for BENTR-free cells (Fig. 2 and Table I) or BENTR-free
cells transfected with an empty pCEP4  vector (data not
shown). The morphologic assessment (Fig. 2) of cell dam-
age showed that, in our experimental conditions, A  in-
duced cell death via both apoptosis and necrosis, as re-
ported previously (24, 58, 59). A  were toxic only in a
fibrillar state, as previously shown (4–6). Reverse order A 
were harmless (not shown).
We also investigated the role of NGF receptor TrkA by
examining the effect of A  on cell clones expressing TrkA
only (BETrkA), or on cell clones expressing both TrkA
and full-length p75NTR (BEp75TrkA). The results (Table I)
show that BETrkA clones were insensitive to the toxic ac-
tion by A , whereas BEp75TrkA clones were sensitive to
the action of A  to the same extent as were BEp75 clones.
The cytotoxic effect of A  was further verified using
MTS reduction test. The data in Fig. 3 show that the MTS
assay gave results similar to those obtained by using the
double-staining epifluorescence method.
Signaling for Cell Death Induced by A  via p75NTR. Our
results show that the toxicity by A  was associated with the
activation of both caspase-8 and caspase-3 in BEp75 cells
(Fig. 4 A). A role for these caspases in A -induced, p75NTR-
mediated cell death was further supported by the finding
(Fig. 4 B) that A  neurotoxicity was prevented by Z-VAD-
FMK, a nonselective inhibitor of caspases, and by Z-IETD-
FMK, a specific inhibitor of caspase-8. In the same experi-
ments, the cell death induced by staurosporine, a well known
protein kinase inhibitor that induces apoptosis, (Fig. 4 B) was
prevented by the unspecific inhibitor of caspases, but could
not be suppressed by the inhibitor of caspase-8. The cyto-
toxic effect by A  was also prevented by DPI (Fig. 4 B), an
inhibitor of oxygen-free radicals forming NADPH oxidase
and of other flavoprotein dehydrogenases (16) indicating that
p75NTR-mediated cell death induced by A  was associated
with the activation of ROI sources and oxidative stress.
The Extracellular Region of p75NTR Is Necessary for the Cyto-
toxic Effect. Two mechanisms might be responsible for the
role of p75NTR in the cytotoxicity by A : (i) p75NTR is per-910 Neuronal Damage by A  Is Mediated by p75NTR Signaling
Figure 1. Expression of
p75NTR in SK-N-BE neuroblas-
toma clones. (A) Schematic de-
piction of the full-length and
truncated p75NTR proteins ex-
pressed in transfected SK-N-BE
clones. Specifically, p75NTR, full-
length receptor; p75 ECD, p75
lacking the extracellular region
(aa 36–230); p75 ICD, p75
lacking the whole cytoplasmatic
region (aa 280–427); p75 DD,
p75 lacking the intracellular DD
(aa 352–427); p75 JICD, p75
lacking the cytoplasmic JICD (aa
275–340). TM, transmembrane
region. (B) p75NTR protein levels
(Western blot analysis) in
BENTR-free cell clones trans-
fected with different constructs
of p75NTR. (C) Localization of
the p75NTR protein at the plas-
mamembrane by immunostaining
with 9992 antiserum in BENTR-
free, BEp75, BEp75 ECD,
BEp75 DD, and BEp75 JICD
cell clones, and with mAb
ME20.4 in BEp75 ICD cell
clones; the detection was per-
formed by Cy3-conjugated anti–
rabbit IgG or anti–mouse IgG; nu-
clei are blue-stained with DAPI.
Figure 2. Epifluorescence microscopic
analysis of cell damage by A . (A1) and
(A2) BENTR-free cells, untreated and
treated for 24 h with A (25–35) (20  M),
respectively. (B1) and (B2) BEp75 cells, un-
treated and treated for 24 h with A (25–35)
(20  M), respectively. A pale green nuclear
fluorescence by AO identifies still normal
cells. A dazzling yellow nuclear fluorescence
by AO (arrowheads) reveals the progressive
chromatin condensation, collapse, and mar-
ginalization proper of apoptosis. A vivid red
fluorescence of chromatin remnants by EB
(arrows) denotes cells, whose membrane in-
tegrity was lost as the death process shifted
from apoptosis to necrosis.  , mitosis.911 Perini et al.
cell damage examined by means of the double staining
with AO and EB were similar to those by A  (Fig. 6 A).
Furthermore the cells treated with NGF or mAb 8211 ap-
peared Annexin V-positive indicating the presence of an
apoptotic process (Fig. 6 B). The signals for cell death
triggered by the binding of NGF or mAb 8211 to the ex-
tracellular region of p75NTR appear to be similar to those
triggered by the binding of A . In fact, also the cell death
by NGF or mAb 8211 was inhibited by Z-VAD-FMK, a
nonspecific inhibitor of caspases, by Z-IETD-FMK, the
specific inhibitor of caspase-8, and by DPI, an inhibitor of
ROI-forming NADPH oxidase and other flavin-dehy-
drogenases (Fig. 4 B).
To clarify the relations between the mechanisms of
p75NTR activation by A , NGF or mAb 8211, we investi-
gated the effect of A  in BEp75 cells, whose p75NTR re-
ceptor had been previously occupied by NGF or mAb
8211. The results (Fig. 5) show that A , NGF, or mAb
8211 exerted cytotoxic activities of comparable magnitude
when added each by itself, but when given serially — mAb
8211 or NGF first and A  next — their cytotoxic effects
were neither additive nor synergistic. These findings sug-
gest that A , NGF, and mAb 8211 act via a similar mecha-
nism by binding the same or closely related sequences of
the extracellular region of p75NTR and thereby triggering
an alike activation of the receptor.
Figure 3. Cell death analysis by MTS assay. BENTR-
free and BEp75 cells were treated with A (25–35) (20
 M), or A (1–42) (5.0  M) for 48 h, then evaluated for
cell viability as compared with untreated controls. Data are
means  SD of four experiments.
Table I. Cell Death Induced by A  Peptides
BENTR-free BEp75 BEp75TrkA
24 h 48 h 24 h 48 h 24 h 24 h
Controls 5.9   2.6a (18) 7.8   2.6 (18) 8.2   2.2 (62) 9.2   2.4 (20) 5.3   2.5 (3) 10.3   2.1 (3)
A (25–35) 5.2   2.6 (12) 6.2   2.8 (12) 29.7   4.5b (65) 34.0   4.8b (14) 7.1   3.1 (5) 28.5   6.3b (5)
A (1–40) 5.6   2.3 (5) 5.5   2.8 (4) 27.6   2.3b (5) 33.2   6.2b (4)
A (1–42) 5.6   1.6 (5) 7.3   1.8 (4) 30.0   2.5b (3) 30.9   2.2b (4)
Cells were treated with A (25–35) (20  M), A (1–40) (5.0  M), or A (1–42) (5.0  M) and cell death was assessed by epifluorescence microscopy
after 24 and 48 h.
aThe values express percentages of cell death and are means  SD of the experiments indicated within brackets.
bP   0.001 with respect to the controls of the corresponding time point.
missive for or potentiates the cytotoxicity by A , as in the
case of excitotoxicity (60); alternatively, (ii) p75NTR is di-
rectly involved in cell death after the binding of A  (25,
26). The validity of the latter mechanism is supported by
the results obtained by using BEp75 ECD cells expressing
a p75NTR truncated in the extracellular region. In the ma-
ture receptor, this region is composed by four 40 aa cys-
teine-rich repeats, the second and the fourth are believed
to be the binding sites for NGF and is linked to the mem-
brane-spanning region by a 61 aa segment rich in proline,
serine and threonine residues (61). Previous results showing
that NGF could displace A  bound to p75NTR-transfected
cells (24) or to neurons spontaneously expressing p75NTR
only (25) led to the conclusion that A  bind to the extra-
cellular region of p75NTR. The results show (Fig. 5) that
BEp75 ECD cells, expressing a p75NTR lacking the four
cysteine repeats of the extracellular region (Fig. 1), were
unaffected by the treatment with A , indicating that A 
interact with and require the extracellular region of p75NTR
to exert their neurotoxic effect.
Furthermore we treated BENTR-free, BEp75, or
BEp75 ECD cell clones with NGF or the mAb 8211,
which interacts with the binding site of NGF (56). The
results (Fig. 5) show that NGF or mAb 8211 induced
cell  death in BEp75, but not in BENTR-free or
BEp75 ECD clones. The morphological aspects of the912 Neuronal Damage by A  Is Mediated by p75NTR Signaling
Role of the Intracellular Region of p75NTR in the Cytotoxicity
by A , mAb 8211, and NGF. The results so far pre-
sented, showing that A  are cytotoxic by binding to the
extracellular region of p75NTR, raise the problem whether
A -binding activates p75NTR and triggers cell death via the
receptor’s intracellular region, or uses p75NTR as an anchor
allowing the induction of cell damage via other mecha-
nisms. To solve this problem, we investigated the effect of
A  on BEp75 ICD cell clones expressing a truncated
p75NTR devoid of the entire intracellular region (Fig. 1).
The results (Fig. 5) show that these cells were insensitive to
the toxic effects of A , NGF, or mAb 8211, indicating that
p75NTR directly participates to the cell damage by these
ligands via the signaling function of its intracellular region.
We next investigated the roles played in p75NTR-depen-
dent cell death by the DD and the JICD domains. In spite
of many studies (41, 46–52), the respective functions of
these two domains remain unclear. We challenged with
A , mAb 8211, or NGF BEp75 DD cell clones express-
ing a truncated p75NTR devoid of the largest part of the
DD (Fig. 1). The results (Fig. 5) show that these cells were
insensitive to the toxic actions of A , mAb 8211, or NGF,
demonstrating that the ligand-induced p75NTR-mediated
cell death does require the function of the DD. As a con-
trol, we found that staurosporine could induce cell death
in all the cell clones expressing various truncated forms of
p75NTR (Fig. 5), indicating that these clones remained sus-
ceptible to apoptogenic agents, whose activity is indepen-
dent of p75NTR signaling. To understand the role of
the juxtamembrane region, we treated BEp75 JICD cell
clones expressing a truncated p75NTR lacking the whole
JICD with A , mAb 8211, or NGF (Fig. 1). The results
(Fig. 5) show that these cells were sensitive to the cyto-
toxic effects of all three ligands, just as BEp75 cells were,
indicating that the function of the JICD is not involved in
the death signaling triggered by such agonists. Here it
is worth noting that, in the absence of agonists,
BEp75 JICD clones exhibited a far higher level of sponta-
neous mortality than did all the other clones we tested
(Fig. 5).
TNF-  and IL-1  Synergize with the A  Neurotoxicity Me-
diated by p75NTR. Several studies have reported that in
AD, besides a direct effect of A  on neurons, cell damage is
due also to an inflammatory reaction mainly correlated
with the activation of microglia and astrocytes by A  to
produce inflammatory mediators, including NO, ROI, IL-
1 , IL-6, TNF- , and monocyte chemoattractant protein
1 (10–16). The role of TNF in brain injury and neurode-
generative diseases is still controversial (62–65). Since neu-
rons within AD plaques are attacked by A , TNF- , and
other cytokines, we investigated the effects of TNF-  on
the A -induced p75NTR-mediated neurotoxicity. For this
purpose we pretreated with this cytokine and then with
A (25 35) BEp75 cell clones, which express TNF recep-
tors (Fig. 7 A). The results show that (i) TNF-  by itself
exerted a slight cytotoxic action and could synergistically
potentiate the toxic effect by A  (Fig. 7 B); (ii) the effects
of both TNF-  by itself and TNF-  plus A  were inhib-
ited by the inhibitor of caspase-8, Z-IETD-FMK (20  M;
Fig. 7 C).
To understand if the synergistic effect is specific of
TNF-  we investigated the activity of IL-1 , another cy-
Figure 4. Metabolic features of cell death induced by A . (A) Time
course of the activation of caspases-8 and -3 as induced by a treatment
with A (25–35) (20  M). Results shown are means  SD of four experi-
ments. (B) Effect of Z-VAD-FMK (100  M), a nonspecific inhibitor of
caspases, of Z-IETD-FMK (20  M), a specific inhibitor of caspase-8, and
of DPI (100 nM), an inhibitor of ROI-forming NADPH oxidase and
other flavoprotein dehydrogenases, on the cytotoxic activity by A (25–
35) (20  M), A (1–42) (5.0  M), NGF (10 nM), mAb 8211 (5.0  g/
ml), and staurosporine (200 nM) in BEp75 cells. Data are reported as
means  SD of three to four experiments (mAb 8211, two experiments).913 Perini et al.
tokine produced by microglia activated by A . After as-
sessing that BEp75NTR cells express the receptor IL-1Rl
(Fig. 7 A) we treated the cell with this cytokine and then
with A  (25–35). The results show (Fig. 7 C) that IL-1 
did not exert by itself a cytotoxic action but synergistically
potentiated A . Again, even the effect of IL-1  plus A 
was inhibited by the inhibitor of caspase-8, Z-IETD-FMK
(20  M).
Discussion
In this work, we addressed two problems, i.e., the role of
p75NTR in the direct mechanism of cell damage by A , and
the possibility that the direct and the indirect (inflamma-
tory) mechanisms of neuronal damage be correlated and,
somehow, coworking.
I. The rationale of the first problem is based on the find-
ings that A -induced cell damage associates with the pres-
ence of p75NTR on the cell surface (24–25). We first con-
firmed (Table I) these findings by using an experimental
model consisting in the treatment with A  of BENTR-
free cell clones devoid of all the neurotrophin receptors and
of BEp75 cell clones expressing full-length p75NTR.
Once we confirmed that p75NTR is necessary for the
toxic action of A , we tried to clarify the mechanism by
which p75NTR works. Three findings demonstrate that the
first step of this mechanism is the interaction of A  with
the external region of this receptor. (i) Consistently with
the previous findings by others (24, 25) that A  bind to
p75NTR, BEp75 ECD cells, which are devoid of the four
cysteine-rich repeats of the extracellular region of the re-
ceptor, were insensitive to the cytotoxic action of A ; (ii)
Figure 5. Effect of A  and p75NTR ago-
nists on cell death in neuroblastoma cell
clones expressing different forms of
p75NTR. BENTR-free cells lacking all the
neurotrophin receptors and clones derived
from them expressing the full length
(BEp75) or differently truncated forms of
p75NTR (compare with Fig. 1) were treated
with A (25–35) (20  M), A (1–42) (5.0
 M), NGF (10 nM), or mAb 8211 (5.0
 g/ml) and staurosporine (100 nM) for
24 h. The results of these experiments are
reported as means  SD of 5–10 experi-
ments. In the case of BENTR-free cells
and BEp75 cells the effects are also shown
of a 2 h pretreatment with NGF (10 nM)
or mAb 8211 (5.0  g/ml) followed by
A (25–35) (20  M). The results are re-
ported as means  SD of three or five ex-
periments when the pretreatment was made
with mAb 8211 or NGF, respectively.914 Neuronal Damage by A  Is Mediated by p75NTR Signaling
p75NTR and are thus potentially involved in signal trans-
duction, i.e., TRAF family proteins, of which TRAF-2 in-
teracts with the helical COOH-terminal region corre-
sponding to the DD, and TRAF-4 and TRAF-6 interact
with the JICD region (46, 50); FAP-1, which binds to the
intracellular region at a COOH-terminal Ser-Pro-Val resi-
due (47); NRIF, which interacts with two discrete se-
quences, the JICD and the DD (49); SC-1, a zinc finger
protein (51), and NRAGE (52), both of which bind to the
JICD region; and NADE (48), RhoA (68) and RIP2 (69)
which bind to the DD. Some data indicate that the JICD
region, but not the DD, is required for neuronal death in
an experimental model, in which a ligand-independent
kind of apoptosis is induced by an overexpressed p75NTR
(41). We have investigated whether the JICD region were
involved in cell death by A , NGF, or mAb 8211, and our
results show (Fig. 5) that this is not the case, because all the
three agonists were toxic for BEp75 JICD cells expressing
a JICD-devoid p75NTR. The reasons for the discrepancy
between our results and those of others (41) remain to be
investigated. The different experimental conditions, i.e., a
ligand-independent apoptotic stimulus in p75NTR-overex-
pressing cells (41), and, as in our case, ligand-dependent ap-
optotic stimuli in cells overexpressing p75NTR along with
the specific composition of p75NTR interactors within these
cells, could be responsible for such a discrepancy. Interest-
ingly, in 1% serum medium, BEp75 JICD cell clones, ex-
pressing a p75NTR devoid of most of the JICD, exhibited a
spontaneous greater mortality than BEp75 cell clones. This
indicates that, under our experimental conditions, the
JICD is necessary for the optimal survival of BEp75 cells.
NGF and mAb 8211, which interacts with the region in-
cluding the binding site of NGF, mimicked the cytotoxic
effect of A  in BEp75 cells expressing the full-length
p75NTR, but were harmless for BEp75 ECD cells, whose
p75NTR lacks the four cysteine-rich repeats; and (iii) the
pretreatment of BEp75 cell clones with NGF or mAb 8211
did not elicit any additive toxic effect by A , likely due to
an hindrance to the binding of A , as suggested by previ-
ous results showing that NGF displaced bound A  from
p75NTR (25, 26).
We do not know what is the precise domain of the ex-
tracellular region of p75NTR responsible for the binding of
A . The fact that A  bind different and structurally unre-
lated receptors (13, 20–27) might suggest that such interac-
tions occur in nonspecific ways (66) and that the binding of
A  to p75NTR takes place in a manner differing from the
recently described interaction between NGF and p75NTR
(67). This raises the problem of whether the binding be-
tween fibrillar A  and p75NTR might activate this receptor
or only permit the tethering of A  to the cell membrane
and its subsequent toxic activity independently of any acti-
vation of p75NTR. The finding that BEp75 ICD cells, re-
taining the extracellular binding region but lacking the
whole intracellular region, were insensitive to the action of
A  clearly demonstrates that, in our experimental model,
cell death by A  requires the activation of p75NTR and its
signaling via the intracellular region. The two main por-
tions of the intracellular region are the DD and the JICD
but the functions of these domains are not yet understood.
Recently, various factors have been identified that interact
with different sequences of the intracellular region of
Figure 6. Epifluorescence microscopic analysis of cell
damage by NGF and mAb 8211. BEp75 cells untreated
and treated for 24 h with NGF (10 nM) or mAb 8211 (5.0
 g/ml) (A) stained with OA plus EB (for details see Fig.
2), or (B) with Annexin V-FITC plus propidium iodide.
(C) Phase contrast images corresponding to those in B.915 Perini et al.
Regarding the role of the DD of p75NTR, our results
show that this domain is necessary for the cell death induced
by A . In fact, BEp75 DD cell clones were insensitive to
the cytotoxic effects by A , NGF, or mAb 8211. These re-
sults agree with those showing that the DD of p75NTR is in-
volved in ligand (NGF)-dependent p75NTR-mediated cell
death via the binding (at aa 338–396) of the cell death exec-
utor protein NADE (48), and in cell death by serum with-
drawal (70) or by p75NTR-induced expression (71).
In conclusion, on the basis of the previous results show-
ing that A  bind to p75NTR (24, 25) and of those presented
here, we propose that the mechanism of p75NTR-mediated
cell death by A  occurs through a cascade of biochemical
processes signaled by the receptor DD. Among these pro-
cesses we have identified the oxidative stress (Fig. 4 B) and
the activation of caspase-8 and -3 (Fig. 4 A), the former be-
ing the proteolytic enzyme mediating signal transduction
downstream the death receptors family (72). Many studies
have been performed on the role of caspases in neuronal
cell death by A  and the results are not conclusive, because
several caspases were found to be activated, i.e., caspase-2
(73), caspase-3 (74), caspase-8 (75, 76), caspase-12 (77),
and caspases-2, -3, and -6 (78). Conversely, caspases-3, -6,
and -9, but not caspase-8, were found to be activated dur-
ing apoptosis by induction of p75NTR expression (71), and
caspases-1, -2, -3, but not -8, in cell death by p75NTR–
bound NGF (79). The reasons for such discrepancies re-
main unclear. In any case, the finding that the specific inhi-
bition of caspase-8 prevented cell death by A  (Fig. 4 B)
could indicate that in our experimental model caspase-8
acts upstream in the cell death signaling.
II. As previously mentioned, it has been suggested that in
AD an inflammatory reaction, which does not involve the
migration of blood cells, but only the local production of
cytokines and other mediators by glial cells, contributes per
se to tissue damage and to A  formation (14, 16, 65).
Herein we have shown that this inflammatory reaction can
cooperate with the direct mechanism of cytotoxicity by
A . In fact, TNF-  and IL-1  can synergistically potenti-
ate the ability of A  to induce death in neuronal cells ex-
pressing the full-length p75NTR (Fig. 7). The finding that
inflammatory mediators, produced by A -activated micro-
glia and astrocytes, were able to synergize with the
p75NTR-mediated toxicity by A  is of relevance for the
pathogenesis of neuronal damage in AD. In fact, the expo-
sure of p75NTR-expressing neurons to A  fibrils and to
TNF-  and/or IL-1  mimics the condition occurring in
the brain of AD, in which both the direct and indirect
mechanisms of cell damage are present and work concur-
rently. Thus, the death signals triggered by p75NTR could
be a unifying pathway upon which converge the effects of
both A  and inflammatory cytokines. It will be of interest
to investigate if other cytokines produced by glial cells acti-
vated by A  (10–16) have a synergistic effect similar to
TNF-  and IL-1 .
III. The findings that p75NTR is involved in neurotoxic-
ity by A  raise some problems worth to be investigated,
such as the type of interaction between p75NTR and A ,
Figure 7. Potentiation by TNF-  and IL-1  of the cytotoxic activity
of A . (A) Flow cytometric analysis of cell surface expression of TNF- 
and IL-1  receptors: (a) fluorescence intensity of cells stained only with
the secondary antibody; (b) with mAb utr-1 against TNFR75; (c) with
mAb H398 against TNFR55; (d) with mAb 8211 against p75NTR as pos-
itive control; (e) with mAb against IL-1RI. (B) Synergistic effect of
TNF-  on the cytotoxicity of A (25–35) (20  M). Data are means
 SD of three experiments. (C) Effect of IL-1  and TNF-  in the pres-
ence or absence of Z-IETD-FMK (20  M). Data are means  SD of 11
experiments in the absence and of three in the presence of Z-IETD-FMK
with TNF-  with and without A  and of five experiments in the ab-
sence and three in the presence of Z-IETD-FMK with IL-1  with and
without A . TNF-  vs. control, *P   0.05 (n   11); **(A [25–35]  
TNF-  vs. A [25 -35]), P   0.001 (n   11); (A [25–35]   IL-1  vs.
A [25 -35]), P   0.001 (n   5); TNF-    Z-IETD vs. TNF- , §P  
0.05 (n   3);  #positive interaction (synergism) versus null interaction
(additive effect) of the two factors, P   0.001 (n   11 for TNF-  and
n   5 for IL-1 ).916 Neuronal Damage by A  Is Mediated by p75NTR Signaling
the structural changes of the receptor triggered by the
bound A  corresponding to the assumption of an activated
state, and the other mechanisms, besides those of the acti-
vation of caspases and oxidative stress, by which neuronal
death is enacted (40, 80).
Another problem, relevant to the pathogenesis of neuro-
degeneration in AD, is the actual role of p75NTR in neu-
ronal damage in vivo. The results of the in vitro experi-
ments presented here and in other reports (24, 25), and the
correlation between the expression of p75NTR and the vul-
nerability of the cholinergic neurons in the brain of AD pa-
tients (38, 39) are in keeping with an involvement of this
receptor. However, one cannot underestimate the fact that
A  can nonspecifically interact with several proteins (66),
and that in vitro A  can induce cell death by interacting
also with other receptors of neuronal surface, such as
RAGE (21),  7NAChR (23), and APP (26), or with addi-
tional molecules, such as phospholipids and gangliosides
(19). Furthermore, our finding that the activity of caspase-8
is stimulated by A , supports the concept that A  activate a
receptor-mediated, rather than a stress-mediated, cell death
pathway. Thus, in AD, alongside with p75NTR, it is likely
that also other receptors or interactors be involved, de-
pending on their distribution and level of surface expres-
sion and on the types and functional states of the neurons
characteristic of the brain regions where the extracellular
formation of fibrillar aggregates can be favored. However,
the results presented here indicate that neurons expressing
p75NTR might be preferential targets of the toxic activity of
A , especially if they express also receptors of TNF or
other cytokines.
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